Advanced molecular diagnostics11/21/2023 ASDs affect as many as 1 in 100 to 1 in 150 children. They are looking forward to potential clients and successful partnerships, and more.The founders' of Advanced Molecular Diagnostics developed DNA sequencing methods that have been licensed by several of the largest biotechnology companies in the world, for use in industry-leading tests for Autism Spectrum Disorders (ASD). Recognized as a deep-tech pioneer, D-nome is the winner of the prestigious Hello Tomorrow Global Deep-Tech Challenge 2021 (for the medical and pharma category), held in Paris, France, selected from over 4000 applicants worldwide with a challenging 8-month long selection process including multiple technical rounds.Īt present, D-Nome team is burning the midnight oil to introduce its innovative D-LAMP product and is currently raising their seed-round for R&D, expansion and product launch. D-nome was selected from over 3000+ applicants in National Bio Entrepreneurship Competition 2021 and won the-Syngene & Cytiva Prizes. They are recipients of the respected BIRAC –BIG Grant and are pre-seed invested by London-based investors Entrepreneur First.ĭ-Nome has participated and won several innovative challenges, bagging distinguished awards in India and international platforms. In just one year of formation, the startup has received the recognition and support of some of the premier biotech incubation centres (AIC-CCMB, C-CAMP & IKP) and organizations like C-CAMP InDx (indigenization of diagnostics) and NASSCOM. Interestingly, D-LAMP technology platform allows for use in multiple adjacent markets including livestock screening, veterinary diagnostics, and agriculture molecular testing.ĭ-Nome’s strength of will is paving their way to success!ĭ-Nome is steadily climbing the ladder of success and the impact it has created in the ecosystem is quite commendable. It is world’s first room-temperature LAMP technology,” states Sujoy Deb, Co-founder & CTO, D-Nome. Its patent-pending reagent composition, is what makes it a reliable, specific, and cost-effective molecular diagnostic platform that has been cross-validated with industry gold-standards. “D-LAMP works on a novel room-temperature technology based on the principles of LAMP isothermal amplification. “Going forward we also aim to expand D-LAMP into point-of-care testing at low-cost settings due to its ease of use and affordability”, explains Divya Sriram, CEO, D-NOME.ĭiagnostic accuracy has been a major concern for molecular tests and D-Nome has been at the forefront in managing this crisis. This is especially designed for diagnostic labs & hospitals to help them reduce their time, effort, and operational costs invested in the entire molecular diagnostics workflow. It is a 1-reagent and 1-step system that helps labs conduct tests in just 30 minutes without sourcing multiple reagents or skilled technicians. How is D-Nome solving the problems of diagnostic labs?ĭ-LAMP’s room temperature RT-PCR technology removes the dependency on RT-PCR machines. The company is virtually incubated at Center of Excellence – IoT & AI, Gurugram, which is a Joint initiative of the Ministry of Electronics & IT (MeitY), Govt. This endeavour is enabling advanced molecular diagnostics like RT-PCR & Genomics (NextGenSeq) to be affordable, scalable and accessible to all. Their amalgamated passion and vision brought into being an innovative D-LAMP platform technology that is based on advanced molecular tools and synthetic biology. A cancer molecular biologist and a genomics expert, the dynamic duo have combined their experiences in molecular diagnostics and Next-generation Sequencing to create a room-temperature LAMP technology. Giving thoughts to the increasing demand for molecular diagnostic approaches especially after the onset of COVID 19, co-founders Divya Sriram & Sujoy Deb envisaged to set up a deep-tech & biotech startup-D-NOME, disrupting molecular diagnostics. In this era of modern yet cost-effective next-generation molecular diagnostics techniques,, healthcare institutions around the world are seamlessly optimizing patient care, enhancing testing accuracy, and selecting appropriate and personalized medicine to treat infectious & genetic diseases, cancer, diabetes, and so forth. This advancement has helped clinicians get a comprehensive analysis of the human genes to understand disorders and diseases and opt for the best treatment for patients. The epoch-making discoveries in the field of molecular diagnostics have remarkably enhanced the healthcare and life-science industry. Fi gure 1 Divya Sriram & Sujoy Deb, Co-Founders
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |